Daré Bioscience, Inc. (DARE)
Daré Bioscience Market Cap : 34.29M for May 1, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.742B |
| Alnylam Pharmaceuticals, Inc. | 39.48B |
| Savara, Inc. | 1.049B |
| BioMarin Pharmaceutical, Inc. | 10.40B |
| Imunon, Inc. | 5.878M |
Market Cap Related Metrics
| PS Ratio | 25.65 |
| PEG Ratio | -0.0088 |
| Price to Book Value | 12.06 |
| Price | 2.355 |
| Earnings Yield | -56.53% |
| PEGY Ratio | -0.0088 |